Intchains Group to Participate in Two Upcoming Investor Conferences

(NASDAQ:ICG), SINGAPORE, Nov. 25, 2025 (GLOBE NEWSWIRE) — Intchains Group Limited (Nasdaq: ICG) (“we,” or the “Company”), a company engaged in the provision of altcoin mining products, strategic acquisition and holding of Ethereum-based cryptocurrencies, and active development of innovative Web3 applications, today announced that Chief Financial Officer, Charles Yan, will participate in two investor conferences […]

Flashpoint Reaches Final Close of $67 Million for the Second Vintage of its Growth Debt Fund

Following a highly successful first vintage,Flashpoint completed a final close of its second Growth Debt Fund (the “Fund”), raising a total of US$67 million. A total of 58 Limited Partners, including international family offices and high-net-worth individuals, have committed to the Fund, including a large portion of investors in the first vintage. The new fund

Cronos Launches Premium Lord Jones Live Resin Fusions(TM) in Canada

(TSX:CRON),(NasdaqGM:CRON), TORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced is expanding its portfolio for its Lord Jones(R) brand with new innovations designed to enhance its lineup of premium cannabis products in the Canadian market. The new Lord Jones

Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences

(NASDAQ:APLS), WALTHAM, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that management will participate in webcast fireside chats at the following investor conferences: Citi's 2025 Global Healthcare Conference Date/Time: Tuesday, December 2, 2025 at 2:30 p.m. ET Evercore 8th Annual Healthcare Conference Date/Time: Wednesday, December 3, 2025 at 2:10

Tenax Therapeutics to Participate in Upcoming Investor Conferences

(NASDAQ:TENX), CHAPEL HILL, N.C., Nov. 25, 2025 (GLOBE NEWSWIRE) — Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, today announced that the Company will present at the following investor conferences: 8th Annual Evercore Healthcare ConferenceFormat: Fireside chatParticipants: Chris Giordano,

Rubico Inc. Announces Time Charter Extensions and Contracted Revenue Backlog of $120.8 Million

(NASDAQ:RUBI), ATHENS, Greece, Nov. 25, 2025 (GLOBE NEWSWIRE) — Rubico Inc. (NASDAQ: RUBI) (the “Company”), an international owner and operator of modern, fuel efficient “ECO” tanker vessels, announced today that it entered into agreements with the time charterer of both its vessels to extend their time charter employment. Specifically, both vessels will continue earning a

Purespring Therapeutics to Present at Piper Sandler’s 37th Annual Healthcare Conference

Purespring Therapeutics to Present at Piper Sandler's 37th Annual Healthcare Conference London – 25 November 2025 – Purespring Therapeutics, a precision nephrology company leading the development of targeted, first-in-class genetic therapies to preserve kidney function, today announced that members of its management team will present at Piper Sandler's 37th Annual Healthcare Conference being held December

Amphista Therapeutics announces new AMX-883 data to be presented at the ASH Annual Meeting and Exposition and provides a business progress update

AMX-883 shows synergistic efficacy in combination with venetoclax in vivo and prevents the emergence of resistance to venetoclax in vitro, addressing a major clinical challenge in acute myeloid leukaemia (AML) AMX-883 showed a significant survival benefit and reduced disease burden compared to control treatments, while being well tolerated in a murine pre-clinical experiment Data provides

Accessibility Resource on Approaching Section 508 Compliance Released by Digital Silk

Digital Silk, an award-winning digital agency focused on creating brand strategies, custom websites, and digital marketing campaigns, announces the publication of a new article offering insights on how organizations can approach building Section 508 compliant websites. The piece outlines practical considerations that may support accessibility efforts for federal agencies, contractors, and businesses aiming to meet

Calumet to Attend Bank of America Leveraged Finance Conference

Calumet, Inc. (NASDAQ: CLMT) (“Calumet”) announced today that it plans to attend the Bank of America Leveraged Finance Conference on Tuesday, December 2nd and will hold one-on-one investor meetings throughout the day. About Calumet Calumet, Inc. (NASDAQ: CLMT) manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to customers across

Scroll to Top